Revenue
$59,000
▼ 86.6% YoY
Net Income
-$78.3M
▼ 122.8% YoY
EPS
$-5.84
▲ 72.1% YoY
Cash
$15.9M
▼ 88.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Doyle Mittie Chief Medical Officer | Vest | Aug 28, 2026 | 679 | $8.04 | $5K | Form 4 ↗ |
Doyle Mittie Chief Medical Officer | Sell | Aug 28, 2026 | 679 | $20.00 | $14K | Form 4 ↗ |
Sullivan Christopher Ryan Chief Financial Officer | Vest | Aug 18, 2026 | 31.0K | $9.88 | $307K | Form 4 ↗ |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Aug 18, 2026 | 31.0K | $20.05 | $622K | Form 4 ↗ |
Sullivan Christopher Ryan Chief Financial Officer | Vest | Aug 17, 2026 | 37.9K | $9.88 | $375K | Form 4 ↗ |
Sullivan Christopher Ryan Chief Financial Officer | Vest | Aug 17, 2026 | 2.9K | $9.88 | $28K | Form 4 ↗ |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Aug 17, 2026 | 37.9K | $19.85 | $753K | Form 4 ↗ |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Aug 17, 2026 | 3.7K | $19.94 | $75K | Form 4 ↗ |
Doyle Mittie Chief Medical Officer | Vest | Aug 17, 2026 | 1.0K | $12.65 | $13K | Form 4 ↗ |
Doyle Mittie Chief Medical Officer | Sell | Aug 17, 2026 | 1.0K | $20.00 | $20K | Form 4 ↗ |
Riley Jennifer Chief Strategy Officer | Sell | Aug 11, 2026 | 2.7K | $19.59 | $52K | Form 4 ↗ |
Doyle Mittie Chief Medical Officer | Vest | Jun 23, 2026 | 1.4K | $8.04 | $12K | Form 4 ↗ |
Doyle Mittie Chief Medical Officer | Sell | Jun 23, 2026 | 1.4K | $18.00 | $26K | Form 4 ↗ |